Lipid-Activated Nuclear Receptors and Sepsis

E-ISSN： 2212-3873|10|3|258-265

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.10, Iss.3, 2010-09, pp. : 258-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathways for Ligand Activated Nuclear Receptors to Unravel the Genomic Responses Induced by Hepatotoxicants

Current Drug Metabolism, Vol. 14, Iss. 10, 2013-01 ,pp. : 1022-1028

Bentham Science Publishers

Access to resources Recommend Favorite

The Nuclear Receptors FXR and LX alpha Potential Targets for the Development of Drugs Affecting Lipid Metabolism and Neoplastic Diseases

Current Pharmaceutical Design, Vol. 7, Iss. 4, 2001-03 ,pp. : 231-259

Bentham Science Publishers

Access to resources Recommend Favorite

Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE₂, PAF, and LPA₁ receptors

By Zhu Tang Gobeil Fernand Vazquez-Tello Alejandro Leduc Martin Rihakova Lenka Bossolasco Michela Bkaily Ghassan Peri Krishna Varma Daya R. Orvoine Robert Chemtob Sylvain

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 3-4, 2006-03 ,pp. : 377-391

NRC Research Press

Access to resources Recommend Favorite

Ligand Recognition by Drug-Activated Nuclear Receptors PXR and CAR: Structural, Site-Directed Mutagenesis and Molecular Modeling Studies

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 937-943

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Determinants of Gastrointestinal and Liver Cancers: Role of Bile Acid Activated Nuclear Receptors

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-03 ,pp. : 625-636

Bentham Science Publishers

Access to resources Recommend Favorite